Lawsuit charges weigh on Bayer profits again

FRANKFURT, Germany (AP) - Charges for lawsuits over its birth control pills weighed on Bayer AG's earnings once again during the fourth quarter of 2012.

The German company said Thursday it made a net profit of (EURO)374 million ($490 million) during the period, compared with (EURO)397 million the previous year.

The company booked (EURO)455 million in charges during the quarter due to current or anticipated lawsuits in the United States over claims of injuries from blood clots associated with its oral contraceptives.

The profit fall masked a 7.3 percent rise in sales to (EURO)9.86 billion.

For the full year, net income declined 1 percent to (EURO)2.45 billion while sales rose 8.8 percent to (EURO)39.8 billion.

Aside from the problems with the contraceptives, the company said its business was doing well, with sales rising across the three basic divisions: prescription and over-the-counter drugs, farm chemicals and seeds, and synthetic materials such as polyurethanes, adhesives and coatings.

Excluding the lawsuit expenses, earnings before interest, taxes and other financial factors rose 9 percent to (EURO)8.24 billion.

Bayer has said it will raise its dividend for 2012 to (EURO)1.90 per share from (EURO)1.65 amid optimism over the coming year. It forecast a percentage increase in operating earnings in the mid-single digit range.

Bayer shares rose 2.6 percent to (EURO)75.71 in morning trading in Europe.


(Copyright 2013 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.)
Top Stories

  • Soda Pop Stop
    The mayors of Seattle, New York and about a dozen other cities want to ban this

  • 'I Am A God'
    Critics say Kanye West's album will change music forever

  • A Skeptic's Doubts
    An ESPN columnist doubts Russell Wilson will ever be elite
MyNorthwest.com - Purpose of Comments statement
Bonneville Media encourages site users to express their opinions by posting comments. Our goal is to maintain a civil dialogue in which readers feel comfortable. At times, the comments can descend to personal attacks. Please do not engage in such behavior. We encourage your thoughtful comments which: have a positive and constructive tone, are on topic, are respectful toward others and their opinions. Bonneville reserves the right to remove comments which do not conform to these criteria.

Comments